Literature DB >> 27149847

Small Molecules Facilitate Single Factor-Mediated Hepatic Reprogramming.

Kyung Tae Lim1, Seung Chan Lee2, Yimeng Gao3, Kee-Pyo Kim4, Guangqi Song5, Su Yeon An6, Kenjiro Adachi4, Yu Jin Jang6, Jonghun Kim1, Kyoung-Jin Oh7, Tae Hwan Kwak1, Seon In Hwang2, Jueng Soo You8, Kinarm Ko1, Seung-Hoi Koo7, Amar Deep Sharma5, Jong-Hoon Kim6, Lijian Hui3, Tobias Cantz9, Hans R Schöler10, Dong Wook Han11.   

Abstract

Recent studies have shown that defined factors could lead to the direct conversion of fibroblasts into induced hepatocyte-like cells (iHeps). However, reported conversion efficiencies are very low, and the underlying mechanism of the direct hepatic reprogramming is largely unknown. Here, we report that direct conversion into iHeps is a stepwise transition involving the erasure of somatic memory, mesenchymal-to-epithelial transition, and induction of hepatic cell fate in a sequential manner. Through screening for additional factors that could potentially enhance the conversion kinetics, we have found that c-Myc and Klf4 (CK) dramatically accelerate conversion kinetics, resulting in remarkably improved iHep generation. Furthermore, we identified small molecules that could lead to the robust generation of iHeps without CK. Finally, we show that Hnf1α supported by small molecules is sufficient to efficiently induce direct hepatic reprogramming. This approach might help to fully elucidate the direct conversion process and also facilitate the translation of iHep into the clinic.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MET; conversion kinetics; direct conversion; induced hepatocytes

Year:  2016        PMID: 27149847     DOI: 10.1016/j.celrep.2016.03.071

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  33 in total

1.  Novel methods for the treatment of liver fibrosis using in vivo direct reprogramming technology.

Authors:  Takeshi Goya; Atsushi Suzuki
Journal:  Stem Cell Investig       Date:  2016-12-09

Review 2.  Small molecules for reprogramming and transdifferentiation.

Authors:  Hua Qin; Andong Zhao; Xiaobing Fu
Journal:  Cell Mol Life Sci       Date:  2017-07-11       Impact factor: 9.261

3.  Chemical cocktails enable hepatic reprogramming of human urine-derived cells with a single transcription factor.

Authors:  Wei Tang; Ren Guo; Shi-Jun Shen; Yang Zheng; Yu-Ting Lu; Meng-Meng Jiang; Xue Cui; Ci-Zhong Jiang; Xin Xie
Journal:  Acta Pharmacol Sin       Date:  2018-10-12       Impact factor: 6.150

Review 4.  Limitations and challenges of direct cell reprogramming in vitro and in vivo.

Authors:  Yi-Xuan Zhang; Si-Lin Chen; Yu-Mei Li; Yun-Wen Zheng
Journal:  Histol Histopathol       Date:  2022-04-13       Impact factor: 2.130

5.  Novel Interactions between Gut Microbiome and Host Drug-Processing Genes Modify the Hepatic Metabolism of the Environmental Chemicals Polybrominated Diphenyl Ethers.

Authors:  Cindy Yanfei Li; Soowan Lee; Sara Cade; Li-Jung Kuo; Irvin R Schultz; Deepak K Bhatt; Bhagwat Prasad; Theo K Bammler; Julia Yue Cui
Journal:  Drug Metab Dispos       Date:  2017-09-01       Impact factor: 3.922

Review 6.  Mesenchymal-epithelial transition in development and reprogramming.

Authors:  Duanqing Pei; Xiaodong Shu; Ama Gassama-Diagne; Jean Paul Thiery
Journal:  Nat Cell Biol       Date:  2019-01-02       Impact factor: 28.824

7.  Stem Cells and Regeneration in the Digestive System: Keystone Meeting.

Authors:  Jelly H M Soffers; Darrick Hansen; Katie L Sinagoga; Bin Li; Martin G Martin; James Wells; Markus Grompe; Linheng Li
Journal:  Gastroenterology       Date:  2016-07-29       Impact factor: 33.883

8.  Role of Hepatic-Specific Transcription Factors and Polycomb Repressive Complex 2 during Induction of Fibroblasts to Hepatic Fate.

Authors:  Shima Rastegar-Pouyani; Niusha Khazaei; Ping Wee; Abdulshakour Mohammadnia; Moein Yaqubi
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

9.  High-efficiency c-Myc-mediated induction of functional hepatoblasts from the human umbilical cord mesenchymal stem cells.

Authors:  Jie Deng; Kai Luo; Pengchao Xu; Qingyuan Jiang; Yuan Wang; Yunqi Yao; Xiaolei Chen; Fuyi Cheng; Dan Xie; Hongxin Deng
Journal:  Stem Cell Res Ther       Date:  2021-07-02       Impact factor: 6.832

10.  Silencing of hepatic fate-conversion factors induce tumorigenesis in reprogrammed hepatic progenitor-like cells.

Authors:  Felipe Serrano; Maria García-Bravo; Marina Blazquez; Josema Torres; Jose V Castell; Jose C Segovia; Roque Bort
Journal:  Stem Cell Res Ther       Date:  2016-07-27       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.